Image pharmaphorum Editor Market Access Why reshoring drug production means embracing continuous man... Recent history should have the pharmaceutical industry questioning some of its fundamental assumptions. Sales & Marketing How can the pharma industry address the gap in talent recrui... Across the economy, several industries have seen a significant increase in staff turnover due to several factors including the COVID-19 pandemic, burnout, and increasing demand for workplac R&D Traditional approaches to growth in biopharma are no longer ... Over the past 15 years, more than 60% of asset growth among the top 30 biopharma companies came from acquisitions. Views & Analysis How can the pharma industry navigate issues in the global su... Supply chain shortages have dominated headlines for several months, and the pharma industry has been no exception. Load more results
Market Access Why reshoring drug production means embracing continuous man... Recent history should have the pharmaceutical industry questioning some of its fundamental assumptions.
Sales & Marketing How can the pharma industry address the gap in talent recrui... Across the economy, several industries have seen a significant increase in staff turnover due to several factors including the COVID-19 pandemic, burnout, and increasing demand for workplac
R&D Traditional approaches to growth in biopharma are no longer ... Over the past 15 years, more than 60% of asset growth among the top 30 biopharma companies came from acquisitions.
Views & Analysis How can the pharma industry navigate issues in the global su... Supply chain shortages have dominated headlines for several months, and the pharma industry has been no exception.
News 23andMe study explains variable results with obesity drugs Gene variants could explain why some people lose more weight than others with GLP-1 drugs, and why some are more prone to side effects.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
